WuXi AppTec to Acquire Texas-Based Global Clinical Trial CRO
WuXi AppTec, China's largest CRO/CMO, will acquire a global clinical-stage contract research company, ResearchPoint Global, of Austin, Texas. Founded in 1999, RPG has 450 employees in 60 countries spread out over Africa, the Americas, Europe and Israel. The company offers a full range of clinical CRO services to small and medium-sized pharmas. WuXi said the acquisition would extend its CRO network around the world. WuXi already has a 500-person China clinical CRO and a clinical research coordinator team with 1,000 employees. Financial details were not disclosed. More details....
Share this with colleagues:
Original Article: WuXi AppTec to Acquire Texas-Based Global Clinical Trial CRO
NEXT ARTICLE
More From BioPortfolio on "WuXi AppTec to Acquire Texas-Based Global Clinical Trial CRO"
